These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Bone mineral density thresholds for pharmacological intervention to prevent fractures. Siris ES, Chen YT, Abbott TA, Barrett-Connor E, Miller PD, Wehren LE, Berger ML. Arch Intern Med; 2004 May 24; 164(10):1108-12. PubMed ID: 15159268 [Abstract] [Full Text] [Related]
7. Relation of androgen receptor gene polymorphism to bone mineral density and fracture risk in early postmenopausal women during a 5-year randomized hormone replacement therapy trial. Salmén T, Heikkinen AM, Mahonen A, Kröger H, Komulainen M, Pallonen H, Saarikoski S, Honkanen R, Mäenpää PH. J Bone Miner Res; 2003 Feb 24; 18(2):319-24. PubMed ID: 12568409 [Abstract] [Full Text] [Related]
8. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes]. Brodowska A. Ann Acad Med Stetin; 2003 Feb 24; 49():111-30. PubMed ID: 15552843 [Abstract] [Full Text] [Related]
11. Ten-year absolute risk of osteoporotic fractures according to BMD T score at menopause: the Danish Osteoporosis Prevention Study. Abrahamsen B, Vestergaard P, Rud B, Bärenholdt O, Jensen JE, Nielsen SP, Mosekilde L, Brixen K. J Bone Miner Res; 2006 May 24; 21(5):796-800. PubMed ID: 16734396 [Abstract] [Full Text] [Related]
14. A common methylenetetrahydrofolate reductase (C677T) polymorphism is associated with low bone mineral density and increased fracture incidence after menopause: longitudinal data from the Danish osteoporosis prevention study. Abrahamsen B, Madsen JS, Tofteng CL, Stilgren L, Bladbjerg EM, Kristensen SR, Brixen K, Mosekilde L. J Bone Miner Res; 2003 Apr 24; 18(4):723-9. PubMed ID: 12674333 [Abstract] [Full Text] [Related]
15. Does hormone-replacement therapy prevent fractures in early postmenopausal women? Randell KM, Honkanen RJ, Kröger H, Saarikoski S. J Bone Miner Res; 2002 Mar 24; 17(3):528-33. PubMed ID: 11874244 [Abstract] [Full Text] [Related]
16. The protective effect of hormone-replacement therapy on fracture risk is modulated by estrogen receptor alpha genotype in early postmenopausal women. Salmén T, Heikkinen AM, Mahonen A, Kröger H, Komulainen M, Saarikoski S, Honkanen R, Mäenpää PH. J Bone Miner Res; 2000 Dec 24; 15(12):2479-86. PubMed ID: 11127213 [Abstract] [Full Text] [Related]
18. The effects of hormone replacement therapy and resistance training on spine bone mineral density in early postmenopausal women. Maddalozzo GF, Widrick JJ, Cardinal BJ, Winters-Stone KM, Hoffman MA, Snow CM. Bone; 2007 May 24; 40(5):1244-51. PubMed ID: 17291843 [Abstract] [Full Text] [Related]